短双歧杆菌YIT4064增强派尔集合淋巴结细胞产生抗流感病毒血凝素抗体的能力。
Augmentation of anti-influenza virus hemagglutinin antibody production by Peyer's patch cells with Bifidobacterium breve YIT4064.
作者信息
Yasui H, Nagaoka N, Hayakawa K
机构信息
Yakult Central Institute for Microbiological Research, Tokyo, Japan.
出版信息
Clin Diagn Lab Immunol. 1994 Mar;1(2):244-6. doi: 10.1128/cdli.1.2.244-246.1994.
Abstract
Bifidobacterium breve YIT4064 was tested an an adjuvant for oral influenza vaccine by the murine Peyer's patch cell culture method. The organism augmented production of anti-influenza virus hemagglutinin immunoglobulin A antibody by Peyer's patch cells in response to addition of hemagglutinin. These antibodies may be disseminated to the respiratory mucosal tissue and prevent influenza virus infection.
摘要
通过鼠派伊尔结细胞培养方法，对短双歧杆菌YIT4064作为口服流感疫苗佐剂进行了测试。该微生物增强了派伊尔结细胞在添加血凝素后产生的抗流感病毒血凝素免疫球蛋白A抗体。这些抗体可能会扩散到呼吸道黏膜组织并预防流感病毒感染。
相似文献
1
Augmentation of anti-influenza virus hemagglutinin antibody production by Peyer's patch cells with Bifidobacterium breve YIT4064.
Clin Diagn Lab Immunol. 1994 Mar;1(2):244-6. doi: 10.1128/cdli.1.2.244-246.1994.
2
Immunogenicity of Bifidobacterium breve and change in antibody production in Peyer's patches after oral administration.
J Dairy Sci. 1989 Jan;72(1):30-5. doi: 10.3168/jds.S0022-0302(89)79076-7.
3
Enhancement of immune response in Peyer's patch cells cultured with Bifidobacterium breve.
J Dairy Sci. 1991 Apr;74(4):1187-95. doi: 10.3168/jds.S0022-0302(91)78272-6.
4
Protection against influenza virus infection of mice fed Bifidobacterium breve YIT4064.
Clin Diagn Lab Immunol. 1999 Mar;6(2):186-92. doi: 10.1128/CDLI.6.2.186-192.1999.
5
Bifidobacterium infantis suppression of Peyer's patch MIP-1α and MIP-1β secretion during Salmonella infection correlates with increased local CD4+CD25+ T cell numbers.
Cell Immunol. 2013 Feb;281(2):134-40. doi: 10.1016/j.cellimm.2013.03.008. Epub 2013 Apr 11.
6
Cholera holotoxin and its B subunit enhance Peyer's patch B cell responses induced by orally administered influenza virus: disproportionate cholera toxin enhancement of the IgA B cell response.
Eur J Immunol. 1990 Feb;20(2):433-6. doi: 10.1002/eji.1830200230.
7
Secretory immunoglobulin A antibodies against the sigma1 outer capsid protein of reovirus type 1 Lang prevent infection of mouse Peyer's patches.
J Virol. 2004 Jan;78(2):947-57. doi: 10.1128/jvi.78.2.947-957.2004.
8
In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "sho-seiryu-to"--stimulation of mucosal immune system and effect on allergic pulmonary inflammation model mice.
Immunopharmacol Immunotoxicol. 1998 May;20(2):267-81. doi: 10.3109/08923979809038544.
9
An intra-Peyer's patch gene transfer model for studying mucosal tolerance: distinct roles of B7 and IL-12 in mucosal T cell tolerance.
J Immunol. 2000 Sep 15;165(6):3145-53. doi: 10.4049/jimmunol.165.6.3145.
10
Alternate mucosal immune system: organized Peyer's patches are not required for IgA responses in the gastrointestinal tract.
J Immunol. 2000 May 15;164(10):5184-91. doi: 10.4049/jimmunol.164.10.5184.
引用本文的文献
1
Modulation of Respiratory TLR3-Anti-Viral Response by Probiotic Microorganisms: Lessons Learned from Lactobacillus rhamnosus CRL1505.
Front Immunol. 2014 May 12;5:201. doi: 10.3389/fimmu.2014.00201. eCollection 2014.
2
Swine-origin influenza-virus-induced acute lung injury: Novel or classical pathogenesis?
World J Biol Chem. 2010 May 26;1(5):85-94. doi: 10.4331/wjbc.v1.i5.85.
3
Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells.
World J Gastroenterol. 2008 Apr 28;14(16):2511-6. doi: 10.3748/wjg.14.2511.
4
Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy.
Langenbecks Arch Surg. 2005 Apr;390(2):104-13. doi: 10.1007/s00423-004-0536-1. Epub 2005 Feb 12.
5
Protection against influenza virus infection of mice fed Bifidobacterium breve YIT4064.
Clin Diagn Lab Immunol. 1999 Mar;6(2):186-92. doi: 10.1128/CDLI.6.2.186-192.1999.
本文引用的文献
1
Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity.
Eur J Immunol. 1984 Apr;14(4):350-6. doi: 10.1002/eji.1830140414.
2
Immunization of dissociated spleen cell cultures from normal mice.
J Exp Med. 1967 Sep 1;126(3):423-42. doi: 10.1084/jem.126.3.423.
3
Biology of the bifidobacteria.
Bacteriol Rev. 1973 Jun;37(2):136-65. doi: 10.1128/br.37.2.136-165.1973.
4
Influenza virus ISCOMs: antibody response in animals.
Vaccine. 1988 Feb;6(1):49-53. doi: 10.1016/0264-410x(88)90014-x.
5
The serum antibody response distributed in subclasses and isotypes after intranasal and subcutaneous immunization with influenza virus immunostimulating complexes.
Scand J Immunol. 1988 Feb;27(2):241-5. doi: 10.1111/j.1365-3083.1988.tb02343.x.
6
The common mucosal immune system and current strategies for induction of immune responses in external secretions.
J Clin Immunol. 1987 Jul;7(4):265-76. doi: 10.1007/BF00915547.
7
Induction, persistence and strain specificity of haemagglutinin-specific secretory antibodies in lungs of mice after intragastric administration of inactivated influenza virus vaccines.
J Gen Virol. 1988 Nov;69 ( Pt 11):2779-84. doi: 10.1099/0022-1317-69-11-2779.
8
Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG.
J Exp Med. 1985 Jan 1;161(1):198-209. doi: 10.1084/jem.161.1.198.
9
Immunogenicity of Bifidobacterium breve and change in antibody production in Peyer's patches after oral administration.
J Dairy Sci. 1989 Jan;72(1):30-5. doi: 10.3168/jds.S0022-0302(89)79076-7.
10
Protection against influenza virus infection by a two-dose regimen of nasal vaccination using vaccines combined with cholera toxin B subunit.
Vaccine. 1989 Aug;7(4):314-20. doi: 10.1016/0264-410x(89)90192-8.
Zotero 插件